抗发炎药的全球市场:各药物类型、用途、给药途径、流通管道、地区 - 规模，占有率，预测，机会分析(2022年～2028年)

关节炎等的急性、慢性疾病增加，预期促进抗发炎药市场成长。可是，抗发炎药的副作用，预计妨碍市场成长。

本报告提供全球抗发炎药市场相关调查分析，市场概要，市场动态，趋势，竞争情形，企业简介等，系统性资讯。

目录

第1章 调查目的、前提条件

第2章 市场展望

• 报告说明
  • 市场定义和范围
• 摘要整理
  • 市场明细:各药物类型
  • 市场明细:各用途
  • 市场明细:各给药途径
  • 市场明细:各流通管道
  • 市场明细:各地区
• Coherent Opportunity Map(COM)

第3章 市场动态、法规、趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 开发平台分析
• 偿付情境
• 流行病学
• PEST分析
• 法规情境
• 新产品的销售
• 联盟、协定
• 市场趋势

第4章 全球抗发炎药市场:冠状病毒(COVID-19)大流行的影响

• COVID-19期间的市场情境
• COVID-19对抗发炎药产品市场的影响

第5章 全球抗发炎药市场:各药物类型(2017年～2028年)

• 简介
• 非类固醇消炎剂(NSAID)
• 免疫选择的抗发炎衍生物(ImSAID)
• 抗发炎生技药品
• 皮质类固醇

第6章 全球抗发炎药市场:各用途(2017年～2028年)

• 简介
• 关节炎
• 慢性阻塞性肺病(COPD)
• 多发性硬化症
• 发炎性肠道疾病(IBD)
• 痛风
• 其他

第7章 全球抗发炎药市场:各给药途径(2017年～2028年)

• 简介
• 口服
• 局部
• 注射
• 吸入

第8章 全球抗发炎药市场:各流通管道(2017年～2028年)

• 简介
• 院内药局
• 零售药局
• 线上药局

第9章 全球抗发炎药市场:各地区(2017年～2028年)

• 简介
• 北美
• 南美
• 欧洲
• 亚太地区
• 中东
• 非洲

第10章 竞争情形

• 热图分析
• 市场占有率分析
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Johnson &Johnson Services Inc.
  • Merck &Company, Inc.
  • Novartis AG
  • Amgen, Inc.
  • AstraZeneca plc
  • Eli Lily and Company
  • AbbVie Inc.
  • F. Hoffmann-La Roche AG
  • Bristol Myers Squibb Company
  • Biogen Inc.
  • Sun Pharmaceutical Industries Ltd
  • Mylan, Inc.
  • Aurobindo Pharma Limited
  • Dr. Reddy's Laboratories
  • 分析师的见解

第11章 Section

Anti-inflammatory drugs are used in the treatment of acute and chronic diseases with inflammatory etiology. Therapeutic delivery of anti-inflammatory drugs to the target site of action and simultaneously avoiding undesired side effects. Anti-inflammatory drug supports to improve the quality of life and management of several rheumatic conditions such as arthritis. Anti-inflammatory drugs, especially the non-steroidal forms has significant role in medical practice, which has strong potential to boost the market growth in the near future.

Market Dynamics

Rising incidence of acute and chronic diseases such as arthritis is expected to drive anti-inflammatory drugs market growth. For instance, according to an article published by the Morbidity and Mortality Weekly Report, an epidemiological digest Centers for Disease Control and Prevention (CDC) in 2017, reports that arthritis affects over 1 in 4 adults and in rural areas in the U.S., 1 in 3 adults has arthritis.

However, side effects of anti-inflammatory drugs are expected to hinder the market growth. For instance, according to an article published by the healthdirect, Australia in January 2020, reports that the anti-inflammatory medicines may also trigger asthma in some people. The same source also states that children under 16 years must not be prescribed aspirin due to the rare occurrence of Reye's syndrome, which is potentially fatal.

Key features of the study:

• This report provides in-depth analysis of the global anti-inflammatory drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global anti-inflammatory drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy's Laboratories among others
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
• The global anti-inflammatory drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-inflammatory drugs market.

Detailed Segmentation:

• Global Anti-inflammatory Drugs Market, By Drug Type:
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  • Anti-inflammatory Biologics
  • Corticosteroids
• Global Anti-inflammatory Drugs Market, By Application:
  • Arthritis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Multiple Sclerosis
  • Inflammatory Bowel Disease (IBD)
  • Gout
  • Others
• Global Anti-inflammatory Drugs Market, By Route of Administration:
  • Oral
  • Topical
  • Injection
  • Inhalation
• Global Anti-inflammatory Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Anti-inflammatory Drugs Market, By Region:
  • North America
    • By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
    • By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
    • By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • U.S.
    • Canada
  • Latin America
    • By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
    • By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
    • By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
    • By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
    • By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
    • By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
    • By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
    • By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
    • By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Drug Type:
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    • Anti-inflammatory Biologics
    • Corticosteroids
    • By Application:
    • Arthritis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Multiple Sclerosis
    • Inflammatory Bowel Disease (IBD)
    • Gout
    • Others
    • By Route of Administration:
    • Oral
    • Topical
    • Injection
    • Inhalation
    • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Pfizer, Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • GlaxoSmithKline plc
  • Johnson & Johnson Services Inc.
  • Merck & Company, Inc.
  • Novartis AG
  • Amgen, Inc.
  • AstraZeneca plc
  • Eli Lily and Company
  • AbbVie Inc.
  • F. Hoffmann-La Roche AG
  • Bristol Myers Squibb Company
  • Biogen Inc.
  • Sun Pharmaceutical Industries Ltd
  • Mylan, Inc.
  • Aurobindo Pharma Limited
  • Dr. Reddy's Laboratories

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Application
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Pipeline Analysis
• Reimbursement Scenario
• Epidemiology
• Pest Analysis
• Regulatory Scenario
• New Product Launches
• Collaborations and Agreements
• Market Trends

4. Global Anti-inflammatory Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Market Scenario
• Impact of COVID-19 Market on the Anti-inflammatory Drugs Products

5. Global Anti-inflammatory Drugs Market, By Drug Type, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Anti-inflammatory Biologics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Corticosteroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Anti-inflammatory Drugs Market, By Application, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Chronic Obstructive Pulmonary Disease (COPD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Multiple Sclerosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Inflammatory Bowel Disease (IBD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Gout
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Injection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Inhalation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

9. Global Anti-inflammatory Drugs Market, By Region, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

10. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Pfizer, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Johnson & Johnson Services Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Merck & Company, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Novartis AG
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Amgen, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • AstraZeneca plc
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Eli Lily and Company
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • AbbVie Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • F. Hoffmann-La Roche AG
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Bristol Myers Squibb Company
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Biogen Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Sun Pharmaceutical Industries Ltd
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Mylan, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Aurobindo Pharma Limited
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Dr. Reddy's Laboratories
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Analyst Views

11. Section

• References
• Research Methodology
• About us and Sales Contact